ATE494376T1 - Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen - Google Patents

Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen

Info

Publication number
ATE494376T1
ATE494376T1 AT08002520T AT08002520T ATE494376T1 AT E494376 T1 ATE494376 T1 AT E494376T1 AT 08002520 T AT08002520 T AT 08002520T AT 08002520 T AT08002520 T AT 08002520T AT E494376 T1 ATE494376 T1 AT E494376T1
Authority
AT
Austria
Prior art keywords
cells
sequence
protein
nucleic acid
iia
Prior art date
Application number
AT08002520T
Other languages
German (de)
English (en)
Inventor
Michel Seve
Alain Favier
Original Assignee
Commissariat Energie Atomique
Univ Joseph Fourier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Univ Joseph Fourier filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE494376T1 publication Critical patent/ATE494376T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
AT08002520T 2002-11-18 2003-11-18 Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen ATE494376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0214374A FR2847263B1 (fr) 2002-11-18 2002-11-18 Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans

Publications (1)

Publication Number Publication Date
ATE494376T1 true ATE494376T1 (de) 2011-01-15

Family

ID=32187667

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08002520T ATE494376T1 (de) 2002-11-18 2003-11-18 Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen
AT03786019T ATE408689T1 (de) 2002-11-18 2003-11-18 Protein spezifisch für die pankreatischen beta- zellen der langerhans-inseln, und seine verwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03786019T ATE408689T1 (de) 2002-11-18 2003-11-18 Protein spezifisch für die pankreatischen beta- zellen der langerhans-inseln, und seine verwendungen

Country Status (12)

Country Link
US (2) US7851164B2 (https=)
EP (3) EP1563071B1 (https=)
JP (2) JP4498144B2 (https=)
CN (2) CN1738900B (https=)
AT (2) ATE494376T1 (https=)
AU (1) AU2003295025B2 (https=)
CA (1) CA2506331C (https=)
DE (2) DE60323664D1 (https=)
DK (2) DK1925667T3 (https=)
ES (3) ES2314268T3 (https=)
FR (1) FR2847263B1 (https=)
WO (1) WO2004046355A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008065544A2 (en) * 2006-09-11 2008-06-05 Mcgill University Genetic predictors of risk for type 2 diabetes mellitus
EP2118309B1 (en) * 2006-12-29 2015-01-28 The Regents of the University of Colorado, a body corporate Diagnostic and therapeutic target for autoimmune diseases and uses thereof
WO2008096009A2 (en) * 2007-02-09 2008-08-14 Mellitech Polymorphism in the slc30a8 gene
WO2009101181A2 (en) * 2008-02-14 2009-08-20 Universite Libre De Bruxelles New plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
CN102171242A (zh) * 2008-09-30 2011-08-31 诺沃-诺迪斯克有限公司 G6PC2编码的β细胞表面标签
WO2010054096A1 (en) * 2008-11-07 2010-05-14 The Cleveland Clinic Foundation Method for detecting and purifying pancreatic beta cells
CN102762731B (zh) * 2009-08-05 2018-06-22 库尔纳公司 通过抑制针对胰岛素基因(ins)的天然反义转录物来治疗胰岛素基因(ins)相关的疾病
EP2537859A1 (en) 2011-06-23 2012-12-26 Université de Mons Molecules specifically binding pancreatic beta cells biomarkers
US8852873B2 (en) 2012-04-13 2014-10-07 Diabetomics, Llc Maternal biomarkers for gestational diabetes
CN104098675A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
CN104098673A (zh) * 2013-04-03 2014-10-15 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
JP6825910B2 (ja) * 2014-03-26 2021-02-03 ヘルムホルツ・ツェントルム・ミュンヒェン・ドイチェス・フォルシュンクスツェントルム・フューア・ゲズントハイト・ウント・ウムベルト（ゲーエムベーハー）Ｈｅｌｍｈｏｌｔｚ Ｚｅｎｔｒｕｍ Ｍｕｅｎｃｈｅｎ Ｄｅｕｔｓｃｈｅｓ Ｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ ｆｕｅｒ Ｇｅｓｕｎｄｈｅｉｔ ｕｎｄ Ｕｍｗｅｌｔ （ＧｍｂＨ） Ｆｌａｔｔｏｐ（Ｆｌｔｐ）はβ細胞成熟についての新規のバイオマーカーである
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520603D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
WO2017189483A1 (en) 2016-04-25 2017-11-02 The Johns Hopkins University Znt8 assays for drug development and pharmaceutical compositions
CN106226526A (zh) * 2016-06-30 2016-12-14 深圳市亚辉龙生物科技股份有限公司 一种锌转运蛋白8抗体化学发光免疫检测试剂盒及其制备方法
EP3652540A4 (en) 2017-07-12 2021-04-07 The Johns Hopkins University PROTEOLIPOSOME-BASED ZNT8 SELF-ANTIGEN FOR DIAGNOSIS OF TYPE 1 DIABETES
WO2020037174A1 (en) * 2018-08-16 2020-02-20 The Johns Hopkins University Antibodies to human znt8
CN109734793B (zh) * 2019-03-14 2022-12-02 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种ZnT8重组蛋白及其制备方法和应用
US20220340911A1 (en) * 2019-08-13 2022-10-27 Amgen Inc. Rnai constructs for inhibiting slc30a8 expression and methods of use thereof
US12366570B2 (en) 2019-10-01 2025-07-22 The Johns Hopkins University Cell-based ZNT8 assay
CA3228876A1 (en) 2021-08-20 2023-02-23 Dax Fu Cell-surface antibody to a specific biomarker of pancreatic beta-cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
NL9001083A (nl) 1990-05-04 1991-12-02 Rijksuniversiteit Beta-cel antigeen.
ZA97476B (en) * 1996-01-22 1998-07-21 Res Dev Foundation Novel methods for the characterization of compounds which stimulate STF-1 expression in pancreatic islet cells.
AU778155B2 (en) * 1999-12-13 2004-11-18 Scripps Research Institute, The Markers for identification and isolation of pancreatic islet alpha and beta cell progenitors
AU2001271284A1 (en) * 2000-06-07 2001-12-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
CA2421576A1 (en) * 2000-09-15 2002-03-28 Curagen Corporation Human polynucleotides and polypeptides encoded thereby
WO2002060953A2 (en) * 2000-12-15 2002-08-08 Agensys, Inc. Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer

Also Published As

Publication number Publication date
ES2314268T3 (es) 2009-03-16
CA2506331A1 (fr) 2004-06-03
WO2004046355A2 (fr) 2004-06-03
US7851164B2 (en) 2010-12-14
ATE408689T1 (de) 2008-10-15
EP2239272A3 (fr) 2010-12-08
EP1563071A2 (fr) 2005-08-17
DK1563071T3 (da) 2009-02-02
AU2003295025B2 (en) 2008-09-18
ES2454592T3 (es) 2014-04-11
JP2010150262A (ja) 2010-07-08
DE60335676D1 (de) 2011-02-17
ES2361639T3 (es) 2011-06-20
EP1925667A1 (fr) 2008-05-28
CN102250242A (zh) 2011-11-23
DE60323664D1 (de) 2008-10-30
JP4498144B2 (ja) 2010-07-07
JP5202550B2 (ja) 2013-06-05
AU2003295025A1 (en) 2004-06-15
CA2506331C (fr) 2015-02-17
CN1738900B (zh) 2011-07-06
FR2847263A1 (fr) 2004-05-21
JP2006506084A (ja) 2006-02-23
EP1925667B1 (fr) 2011-01-05
EP2239272A2 (fr) 2010-10-13
FR2847263B1 (fr) 2006-01-13
WO2004046355A3 (fr) 2004-09-30
DK1925667T3 (da) 2011-04-26
EP2239272B1 (fr) 2014-01-01
US20110027807A1 (en) 2011-02-03
EP1563071B1 (fr) 2008-09-17
US9568482B2 (en) 2017-02-14
US20060246442A1 (en) 2006-11-02
CN1738900A (zh) 2006-02-22

Similar Documents

Publication Publication Date Title
ATE494376T1 (de) Spezielles protein der pankreatischen beta-zellen der langerhans-inseln und seine anwendungen
JP2006506084A5 (https=)
RU2009135270A (ru) Способы выявления воспалительного заболевания кишечника
EP2088207A1 (en) Biomarkers and methods for identification of agents useful in the treatment of affective disorders
CN101568646A (zh) 基因扩增用引物对、含有其的基因扩增用试剂及其用途
KR20200073407A (ko) 돼지 정액의 품질 판별용 단일염기다형성(snp) 마커 및 이의 용도
AU2012335087B2 (en) Polypeptide substrate for the detection of von Willebrand factor cleaving protease ADAMTS13
ES2373044T3 (es) Procedimientos y composiciones para predecir la respuesta a warfarina.
KR102124652B1 (ko) 개의 불안장애 조기 예측 또는 진단용 조성물
ZA200606354B (en) Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof
US10704098B2 (en) Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis
KR102144673B1 (ko) 참외의 품종 구별 및 f1 종자 순도검정을 위한 snp 기반 kasp용 프라이머 세트 및 이의 용도
EP3123169A1 (en) Flattop (fltp) is a novel biomarker for beta cell maturation
CN103525904A (zh) 利用高分辨熔解曲线分析技术检测线粒体乙醛脱氢酶基因分型的方法
PT1131424E (pt) Mutações do gene da parkina, composições, métodos e utilizações
CN106434947B (zh) Wnt5a基因作为猪产仔数性状相关检测的分子标记
KR20170048206A (ko) XBP-1(X-box binding protein 1) 유전자를 이용한 소포체 스트레스 분석용 조성물
EP2586787A1 (en) DEP2 and its uses in major depressive disorder and other related disorders
JP7833917B2 (ja) 汗腺細胞および汗腺組織の老化を評価する方法、並びに、被験試料の汗腺細胞および汗腺組織に対する老化調整効果を評価する方法
JPWO2018199136A1 (ja) Ａｂｌ１ ｔ３１５ｉ変異の発現レベルの測定方法
CN101109705A (zh) 一种检测酒精中毒和酒精成瘾易感性的试剂盒
DE602004020603D1 (de) Verfahren zum nachweis des gens einer mutante des pankreatischen insel-amyloidproteins sowie nukleinsäuresonde und kit dafür
CN104630362A (zh) 一种精子细胞转录调控相关基因的基因检测方法
JP4430063B2 (ja) Ｗｆｄｃ１の変異を検出する先天性眼疾患の検査方法
Brianna et al. Developmental and cell-specific expression of Cacna1d splice variants

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties